Integra LifeSciences Cor...

NASDAQ: IART · Real-Time Price · USD
14.14
0.52 (3.82%)
At close: Aug 15, 2025, 3:05 PM

Integra LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
n/a n/a 19.43M -10.7M -12.4M -3.28M 19.83M 19.5M 4.18M 24.23M 52.95M 49.91M 44.79M 32.9M 45.38M 43.23M 35.07M 45.39M
Depreciation & Amortization
n/a n/a 37.59M 35.96M 36.78M 30.57M 30.52M 30.56M 30.83M 31.14M 29.5M 29.47M 29.61M 29.72M 30.75M 30.12M 29.75M 29.21M
Stock-Based Compensation
n/a n/a 7.15M 4.38M 7.24M 5.6M 5.79M 5.46M 5.27M 3.62M 5.73M 8.97M 6.74M 6.29M 6.43M 7.75M 15.7M 6.33M
Other Working Capital
n/a -14.41M 25.41M -2.86M -9.16M -1.5M 25.06M -12.25M 3.27M 20.37M 6.83M 4.17M 613K -5.34M -23.06M -775K -612K -2.9M
Other Non-Cash Items
n/a -9.43M 5.54M -20.53M 80.39M 2M 7.36M 4.08M 3.22M -14.42M -7.07M -10.75M -1.94M 1.65M -159.15M 164.69M 2.96M -36.6M
Deferred Income Tax
n/a -1.83M -6.99M -9.04M -1.84M -2.86M -14.85M 1.24M -227K 1.95M -6.02M -6.1M 4M 3.54M 10.74M -8.59M -3.67M -1.23M
Change in Working Capital
n/a n/a -11.99M 22.41M 938K -23.35M 10.09M -34.06M -14.99M -20.37M 10.26M -3.19M -16.72M -29.77M -25.25M 5.95M 11.49M 25.97M
Operating Cash Flow
-2.34M -11.26M 50.74M 22.48M 40.4M 15.76M 58.75M 26.77M 28.28M 26.16M 85.33M 68.31M 66.48M 44.34M -91.09M 243.15M 91.29M 69.08M
Capital Expenditures
n/a n/a -39.55M -29.65M -29.71M -15.46M -24.54M -13.08M -15.55M -13.7M -14.46M -9.15M -9.41M -14.07M -27.48M -7.29M -6.63M -6.67M
Cash Acquisitions
n/a n/a 4.18M n/a -281.99M n/a n/a n/a n/a n/a -51.51M 23.96M n/a n/a -190.47M -1.27M -1.28M -110.89M
Purchase of Investments
n/a n/a -4.13M n/a -10.5M -38.5M -32.69M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 35.25M 19.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-57.57M -35.92M -9.95M n/a -10.5M -38.5M -32.69M 5.38M n/a n/a 11.14M 23.96M 4.91M -4.74M 315.95M -125.4M n/a 191.74M
Investing Cash Flow
-57.57M -35.92M -4.25M -10.4M -322.2M -53.97M -57.23M -7.7M -15.55M -13.7M -54.82M 14.8M -4.5M -14.07M 98M -133.96M -7.92M -117.57M
Debt Repayment
n/a 39.16M -4.54M -19.74M -31.74M 355.4M -6.8M 74.9M -11.7M -2.2M -101.3M -6.5M 500K -500K 800K -800K -98.4M -1.6M
Common Stock Repurchased
n/a n/a -2.47M 3.12M -50M -3.12M -314K -125M -104K -150M -272K -1.14M -14M -125M -515K -442K -207K -3.64M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
14.24M 35.38M -136K -171K -12M 3.28M 225K 441K 1.01M -10.48M 3.6M -1.14M -13.65M -9.2M -279K 2.54M 925K -1.42M
Financial Cash Flow
14.24M 35.38M -7.15M -19.91M -93.75M 358.68M -6.89M -49.66M -10.69M -162.68M -97.7M -7.64M -13.15M -133.47M 101.01M -98.75M -97.47M -3.02M
Net Cash Flow
-28.46M -7.27M 31.22M -79K -376.67M 315.5M 2.67M -344.65M 1.82M -149.29M -55.28M 64.78M 40.06M -106.36M 43.22M 72.82M -11.56M -61.19M
Free Cash Flow
-2.34M -11.26M 11.19M -7.16M 10.69M 291K 34.22M 13.69M 12.73M 12.45M 70.88M 59.16M 57.07M 30.28M -118.58M 235.86M 84.66M 62.41M